Literature DB >> 23601221

Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.

Karen Anavi-Lev1, Yakir Anavi, Gavriel Chaushu, Dror M Alon, Gavriel Gal, Ilana Kaplan.   

Abstract

OBJECTIVES: Clinico-pathological evaluation of bisphosphonate (BP)-related osteonecrosis of jaws, comparison between oral (PO) and intravenous (IV) BPs and histomorphometric analysis of associated actinomyces. STUDY
DESIGN: Retrospective clinical and histomorphometric analysis. Data on background, clinical, treatment and follow-up were analyzed. Actinomyces colonies were identified by typical filamentous colony morphology, Gram, and PAS stains. Colony density and relative colony surface area were measured.
RESULTS: Fifty-two patients were included, 37 (71.2%) IV, 15 (28.8%) PO BPs. with a mean duration of 2.33 and, 4.33 years respectively. One hundred percent of cases exhibited actinomyces colonization. The relative colony surface area was significantly higher in PO treatment (P = .024), with no differences in density, healing time or antibiotic treatment periods. High frequency of diabetes mellitus (60% PO cases) and corticosteroid treatment (25% of cases) were recorded.
CONCLUSION: Infection with actinomyces is a common denominator in BP-related osteonecrosis of the jaws (BRONJ), regardless of administration route. Diabetes and corticosteroid treatment seem to be important contributing factors for BRONJ.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601221     DOI: 10.1016/j.oooo.2013.03.001

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  15 in total

1.  Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.

Authors:  D Yoshiga; M Sasaguri; K Matsuo; S Kokuryou; M Habu; M Oda; M Kodama; H Tsurushima; O Sakaguchi; T Sakurai; J Tanaka; Y Morimoto; I Yoshioka; K Tominaga
Journal:  Osteoporos Int       Date:  2015-06-03       Impact factor: 4.507

2.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

Review 3.  Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?

Authors:  J De Ceulaer; E Tacconelli; S J Vandecasteele
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-01       Impact factor: 3.267

4.  Concomitant factors leading to an atypical osteonecrosis of the jaw in a patient with multiple myeloma.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Josep Anton Giménez-Rubio
Journal:  Case Rep Med       Date:  2014-07-16

Review 5.  Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary.

Authors:  A M Hinson; C W Smith; E R Siegel; B C Stack
Journal:  Int J Dent       Date:  2014-06-24

6.  Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.

Authors:  Tae-Hwan Kim; Won-Gyo Seo; Chul-Hong Koo; Jae-Hoon Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-08-24

7.  Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?

Authors:  L Bagan; Y Jiménez; M Leopoldo; A Rubert; J Bagan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-09-01

8.  Diabetes Mellitus and Its Association to the Occurrence of Medication-Related Osteonecrosis of the Jaw.

Authors:  Roman K Rahimi-Nedjat; Keyvan Sagheb; Andreas Pabst; Lukas Olk; Christian Walter
Journal:  Dent J (Basel)       Date:  2016-05-31

9.  Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats.

Authors:  Felipe M Silveira; Adriana Etges; Marcos B Correa; Ana Carolina U Vasconcelos
Journal:  J Oral Maxillofac Res       Date:  2016-12-28

10.  Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment.

Authors:  Seung-Hun Lee; So-Young Choi; Min-Su Bae; Tae-Geon Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.